Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.

CONCLUSION: HBcAb+ liver grafts do not affect the long-term outcome of the recipients. Combined with proper postoperative antiviral prophylaxis, utilization of HBcAb+ grafts is rational and feasible.
PMID: 30622380 [PubMed - in process]

Source: World Journal of Gastroenterology - December 28, 2018 Category: Gastroenterology Authors: Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG Tags: World J Gastroenterol Source Type: research